MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Analysing an extension type of Parkinson’s disease

    R. Kikuchi, T. Okamoto, S. Akaike, M. Miller, M. Kawamura (Yokohama, Japan)

    Objective: We analyse an extension type of Parkinson’s disease. Background: At the International Congress of the Movement Disorder Society last year, we reviewed a patient…
  • MDS Virtual Congress 2020

    First Scientific Description of the Hepato-Lenticular Degeneration

    D. Labunskiy, S. Kiryukhina, N. Kolmykova (Saransk, Russian Federation)

    Objective: Hepato-Lenticular Degeneration (HLD) first described by German pathologist Friedrich Theodor von Frerichs in 1854, but in the West it called Wilson's Disease. In Russia…
  • MDS Virtual Congress 2020

    Sleep and Polysomnographic Abnormalities in Indian Patients with Huntington’s Disease

    J. Annapureddy, S. D V, N. Kamble, P. Pal, S. Jain, B. Kutty, R. Yadav (Bangalore, India)

    Objective: To study the sleep abnormalities in patients with HD by usingquestionnaire and Video Polysomnography (VPSG) and correlate with the eye movement abnormalities. Background: About 87.8% of the patients report some sleep disturbance…
  • MDS Virtual Congress 2020

    Huntington’s Disease in Israel – 20 years of follow up from Maccabi Healthcare Services

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe Huntington’s Disease (HD) epidemiology in Israel and depict comorbidities and longitudinal healthcare resources utilization. Background: HD is a rare, inherited neurodegenerative disorder,…
  • MDS Virtual Congress 2020

    HD Constellation: A novel patient-centred approach to enriching clinical datasets by combining medical record chart review and Enroll-HD

    K. Belendiuk, J.P Sacksteder, X. Sanii, E. Neacy, J. Levey, E. Korner, R. Houghton, G. Yohrling (South San Francisco, CA, USA)

    Objective: HD Constellation aims to create a dataset providing a longitudinal view of the Huntington’s disease (HD) course, based on physician-provided medical records in the…
  • MDS Virtual Congress 2020

    Longitudinal Utility of the Montreal Cognitive Assessment and Mini Mental State Exam in Huntington’s disease (HD)

    I. Beltran-Najera, J. Corey-Bloom, C. Snell, A. Smirnova, P. Gilbert (San Diego, CA, USA)

    Objective: Neuropsychological assessments are useful tools for examining and tracking cognitive impairment in individuals with neurological disorders; however, a full neuropsychological battery is not realistic…
  • MDS Virtual Congress 2020

    Performance at the Category-Exemplars language test (CATEX) in Parkinson’s disease and Huntington’s disease Italian population

    R. Biundo, T. Gandolfi, M. Garon, E. Fiorenzato, G. Arcara, C. Jaquemont, P. Bisiacchi, C. Semenza, A. Antonini (Venice-Lido, Italy)

    Objective: This study aims to explore CATEX sensitivity to detect early cognitive deficits in Huntington’s disease (HD) and Parkinson’s disease (PD) Italian population. Background: PD…
  • MDS Virtual Congress 2020

    Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

    D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)

    Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…
  • MDS Virtual Congress 2020

    Can Handwriting Movement Abnormalities Serve as an Early Biomarker of Transition to Manifest Huntington’s disease?

    J. Corey-Bloom, A. Hall, C. Snell, B. Wright, M. Caligiuri (La Jolla, CA, USA)

    Objective: The objective of this study was to examine whether handwriting abnormalities are present prior to clinically manifest chorea in Huntington's disease (HD) and can…
  • MDS Virtual Congress 2020

    Modelling Huntington’s disease diagnosed prevalence from diagnosed incidence and survival time

    V. Crowell, R. Houghton, F. Squitieri, A. Tomar, T. Fernandes (Basel, Switzerland)

    Objective: To develop an epidemiological model of manifest Huntington’s disease (HD) to estimate international HD diagnosed prevalence by Shoulson–Fahn Total Functional Capacity (TFC)-based Stage based…
  • « Previous Page
  • 1
  • …
  • 776
  • 777
  • 778
  • 779
  • 780
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley